New Project Seeks to Understand Vulnerable Plaque

Those who are most likely to die from coronary artery disease are those who have what is called "vulnerable plaque," a form of plaque prone to rupture. But as of now, little is known about how it forms, what causes it to rupture, and who is likely to get it. So, reports the New York Times, drug, genomics, health insurance and diagnostics companies are teaming up to fund a $30 million research program that hopes to get to the bottom of these questions.

November 27, 2006

1 Min Read
MDDI logo in a gray background | MDDI

Contributing on the diagnostics side is Phillips, which is expected to provide computed tomography equipment to scan the hearts and arteries of the 4,000 to 6,000 patients in the project. On the device side, Abbott has a separate 700-patient study on this topic, inherited from Guidant when it bought that firm's stent operations. It's not clear what these studies might yield and whether devices can be of help to whatever is learned. But it's important they proceed.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like